Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001236314 | SCV001409034 | pathogenic | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-06-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln54*) in the SDHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHA are known to be pathogenic (PMID: 22974104, 24781757). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with gastrointestinal stromal tumors (PMID: 23060355). ClinVar contains an entry for this variant (Variation ID: 962458). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001565032 | SCV001788298 | pathogenic | not provided | 2024-04-25 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25394176, 22974104, 24886695, 30201732, 36980917, 23060355) |
Myriad Genetics, |
RCV004789489 | SCV005406070 | pathogenic | Paragangliomas 5 | 2024-08-20 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |